EUPRAXIA PHARMACEUTICALS INC. Foreign Currency Transaction Gain (Loss), before Tax
EUPRAXIA PHARMACEUTICALS INC. (EPRX) reported Foreign Currency Transaction Gain (Loss), before Tax of -$1.56 million for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-13.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2026-03-13
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 12 month |
|---|---|
| 2025-12-31 | -$1.56M 40-F · filed 2026-03-13 |
| 2024-12-31 | -$159.21K 40-F · filed 2026-03-13 |
| 2023-12-31 | $66.29K 40-F · filed 2025-03-20 |
| 2022-12-31 | $240.55K 40-F · filed 2024-04-01 |